Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1980
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
A03FA01
|
| gptkbp:blackBoxWarning |
tardive dyskinesia
|
| gptkbp:CASNumber |
364-62-5
|
| gptkbp:chemicalFormula |
C14H22ClN3O2
|
| gptkbp:contraindication |
gptkb:pheochromocytoma
gastrointestinal hemorrhage mechanical bowel obstruction |
| gptkbp:eliminationHalfLife |
5-6 hours
|
| gptkbp:excretion |
urine
|
| gptkbp:genericName |
gptkb:metoclopramide
|
| https://www.w3.org/2000/01/rdf-schema#label |
Reglan
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
various generic manufacturers
|
| gptkbp:mechanismOfAction |
dopamine antagonist
serotonin receptor modulator |
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
oral
intramuscular intravenous |
| gptkbp:sideEffect |
fatigue
restlessness drowsiness tardive dyskinesia |
| gptkbp:usedFor |
gptkb:gastroesophageal_reflux_disease
nausea vomiting gastroparesis |
| gptkbp:bfsParent |
gptkb:Metoclopramide
gptkb:metoclopramide |
| gptkbp:bfsLayer |
7
|